¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"periaqueductal gray substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • paramagnetic substance
    »óÀÚ¼º¹°Áú
  • reducing substance
    ȯ¿ø¹°Áú
  • reticular substance
    ±×¹°±¸¼º¹°Áú, ¸Á»óü
  • radioactive substance
    ¹æ»ç¼º¹°Áú
  • specific soluble substance
    ƯÀ̰¡¿ë¹°Áú
  • spongy substance
    °¹¼ØÁú, ÇØ¸éÁú
  • substance
    ¹°Áú
  • substance P
    ¼­ºê½ºÅĽºP, ¹°ÁúP
  • substance withdrawal
    ¹°Áú±Ý´Ü
  • slow-reacting substance
    Áö¿¬¹ÝÀÀ¹°Áú
  • visual substance
    ½Ã°¢¹°Áú
  • volatile substance
    Èֹ߹°Áú
  • white substance
    ¹é(»ö)Áú
  • zymoplastic substance
    ÀÀÇ÷ÃËÁø¹°Áú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • enzyme trace substance theory
    È¿¼ÒÈçÀû¹°¼³
  • erythrocyte sensitizing substance
    ÀûÇ÷±¸¹Î°¨¹°Áú
  • exophthalmos-producing substance
    ´«µ¹ÃâÀ¯¹ß¹°Áú
  • ferromagnetic substance
    ¼¾ÀÚ¼º¹°Áú, °­ÀÚ¼ºÃ¼
  • fibrinoid substance
    ¼¶À¯¼Ò¼º¹°Áú
  • fundamental substance
    ¹«ÇüÁú
  • gap substance
    »çÀ̹°Áú
  • gelatinous substance
    ¾Æ±³Áú
  • goitrogenic substance
    ¹æÆÐ»ùÁ¾À¯¹ß¹°Áú, °©»ó»ùÁ¾À¯¹ß¹°Áú
  • ground substance
    ¹ÙÅÁÁú
  • heparinoid substance
    ÇìÆÄ¸°¼º¹°Áú
  • heterogeneous substance
    ºÒ±ÕÁúü
  • horny substance
    °¢Áú
  • inducer substance
    À¯µµ¹°Áú
  • inhibitor substance
    ¾ïÁ¦¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gray syndrome
    ȸ»öÁõÈıº.
  • gray-scale
    ȸ»öÁ¶
  • pneumonia,gray hepatization
    ȸ»ö°£È­(°£º¯)(üéß䰣ȭ(°£º¯))
  • posterior gray commissure
    µÚȸ»öÁú¸Â±³Â÷
  • C-substance
    C-¹°Áú.
  • EPS=£¾exophthalmos producing substance
    ¾È±¸µ¹ÃâÀ¯¹ß¹°Áú.
  • Goitrogenic substance
    °©»ó¼±Á¾À¯¹ß¹°Áú(Ë£ßÒàÍðþë¯Û¡Úªòõ)
  • Inducer substance
    À¯µµ¹°Áú(ë¯ÓôÚªòõ)
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • Kerry reducing substance test
    Äɸ®È¯¿ø¹°Áú½ÃÇè
  • Mullerian inhibiting substance
    ¹°·¯°ü ¾ïÁ¦¹°Áú
  • P substance
    P¹°Áú
  • SRS A : slow reacting substance A
    ¿¡½º¾Ë¿¡½º-¿¡ÀÌ.
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
  • accessory food substance
    ºÎ¿µ¾ç¹°(Üùç½å×Úª).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gray spinal syndrome
    ô¼öȸ»öÁúÁõÈıº(ô±âÐüéßäòõñøý¦ÏØ).
  • gray syndrome
    ȸ»öÁõÈıº.
  • gray-scale
    ȸ»öÁ¶
  • pneumonia,gray hepatization
    ȸ»ö°£È­(°£º¯)(üéß䰣ȭ(°£º¯))
  • posterior gray commissure
    µÚȸ»öÁú¸Â±³Â÷
  • accelerans substance
    ÃËÁø¹°Áú(õµòäÚªòõ).
  • accessory food substance
    ºÎ¿µ¾ç¹°(Üùç½å×Úª).
  • acrosomal substance
    ÷´Üü¹°Áú
  • agglutinable substance
    ÀÀÁý¼º ¹°Áú(ëêó¢àõÚªòõ).
  • anterior perforated substance
    ¾Õ°üÅëÁú
  • anterior pituitary-like substance
    ³úÇϼöü Àü¿±À¯»ç¹°Áú(¡­×¾ÞÄÚªòõ).
  • antibacterial substance
    Ç×±Õ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antifungal substance
    Ç×Áø±Õ¼º ¹°Áú.
  • antiketogenic substance
    Ç×ÄÉÅæ»ý¼º¹°Áú.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Central gelatinous substance
    Á߽ɾƱ³Áú
    [¿¾ ¿ë¾î] Á߽ɱ³¾çÁú
  • Central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
    [¿¾ ¿ë¾î] Áß°£ÁúÁ߽ɺÎ
  • Postacrosomal substance
    ÷´ÜüµÚ¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÈŰÁú
  • Postacrosomal substance
    ÷´ÜüµÚ¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÈÄÁú
  • Acrosomal substance
    ÷´Üü¹°Áú
    [¿¾ ¿ë¾î] ÷´Üü¹°Áú
  • Acrosomal substance
    ÷´Üü¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÁú
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇϹ°Áú
  • Subacrosomal substance
    ÷´Üü¹Ø¹°Áú
    [¿¾ ¿ë¾î] ÷´ÜüÇÏÁú
  • Substance of synaptic cleft
    Æ´»õ¹°Áú
    [¿¾ ¿ë¾î] ¿­³»Áú
  • Osteoid substance
    Dz»À¹°Áú
    [¿¾ ¿ë¾î] °ñ¾çÁú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SPS Sleep Promoting Substance
SRS-A Slow Reacting Substance of Anaphylaxis
ADS acute death syndrome; acute diarrheal syndrome; Alcohol Dependence Scale; alternative delivery syste...
ALS acute lateral sclerosis; advanced life support; afferent loop syndrome; amyotrophic lateral sclerosi...
AMS ablepharon-microstomia syndrome; acute mountain sickness; adenosylmethionine synthetase; aggravated ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PAG Periaquaeductal gray matter
SGL Superficial gray layer
cGy centi-Gray
MCG midbrain central gray
vlPAG ventrolateral periaquaductal gray
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • osteoid substance
    Dz »À ¹°Áú
  • pain producing substance
    µ¿Åë À¯¹ß ¹°Áú
  • psychoactive substance-induced organic mental disorder
    ȰÁ¤½Å¼º ¹°Áú·Î À¯µµµÈ ±âÁúÀû Á¤½Å Àå¾Ö
    ȰÁ¤½Å¼º ¹°ÁúÀÇ »ç¿ë°ú °ü·ÃµÈ ±âÁúÀû ³ú ÁõÈÄ. ¿­ °¡Áö Ư¼ö ÁõÈĸ¦ Æ÷ÇÔÇϰí Àִµ¥ Áßµ¶, Áß´Ü Áõ»ó, ¼¶¸Á, Ä¡¸Å, °Ç¸Á Àå¾Ö, ¸Á»ó Àå¾Ö, ȯ°¢, °¨Á¤ Àå¾Ö, Áö°¢ Àå¾Ö ¹× ÀÎ°Ý Àå¾Ö µîÀÌ´Ù. ¾ËÄÝ Áßµ¶°ú °°ÀÌ ¿øÀÎ ¹°ÁúÀÌ ¾Ë·ÁÁ® ÀÖÀ¸¸é À̸¦ ¸í±âÇÑ´Ù.
  • radioactive substance
    ¹æ»ç¼º ¹°Áú
  • receptive substance
    ¼ö¿ë ¹°Áú
    ±ÙÀ° Á¶Á÷, ƯÈ÷ ½Å°æÀÇ ¿îµ¿ Á¾ÆÇ ±Ùó¿¡ ÀÖÀ¸¸ç ÈïºÐÀ» ÀüµµÇÏ´Â °ÍÀ¸·Î »ý°¢µÇ´Â ¹°Áú.
  • slow-reating substance
    Áö¹ÝÀÀ¼º ¹°Áú
    ¾î¶² ÆòȰ±ÙÀÇ ´À¸®°í Áö¼Ó¼ºÀÎ ¼öÃàÀ» ÀÏÀ¸Å°´Â ¾Æ³ªÇʶô½Ã ¹ÝÀÀ ½Ã¿¡ ¹æÃâµÇ´Â ¹°Áú ±âÈ£ SRS-A.
  • substance defect
    ¹°Áú °áÇÌ
  • substance P fiber
    P ¹°Áú ¼¶À¯
  • toxic substance
    À¯µ¶ ¼ººÐ, µ¶¹°
  • transmitter substance
    Àü´Þ ¹°Áú
  • white substance
    ¹é»ö Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
deep gray layer of superior colliculus A layer of myelinated fibres, the deepest layer of the colliculus superior, delimiting the latter from the central gray substance surrounding the cerebral aqueduct.
Synonym: stratum album profundum.
(05 Mar 2000)
digital gray scale 1. Extent from side to side, or distance sidewise from a given point or line; breadth; width. "Provided the length do not exceed the latitude above one third part." (Sir H. Wotton)
2. Room; space; freedom from confinement or restraint; hence, looseness; laxity; independence. "In human actions there are no degrees and precise natural limits described, but a latitude is indulged." (Jer. Taylor)
3. Extent or breadth of signification, application, etc.; extent of deviation from a standard, as truth, style, etc. "No discreet man will believe Augustine's miracles, in the latitude of monkish relations." (Fuller)
4. Extent; size; amplitude; scope. "I pretend not to treat of them in their full latitude." (Locke)
5. <geography> Distance north or south of the equator, measured on a meridian.
6. <astronomy> The angular distance of a heavenly body from the ecliptic. Ascending latitude, Circle of latitude, Geographical latitude, etc. See Ascending. Circle, etc. High latitude, that part of the earth's surface near either pole, especially. That part within either the arctic or the antarctic circle. Low latitude, that part of the earth's surface which is near the equator.
Origin: F. Latitude, L. Latitudo, fr. Latus broad, wide, for older stlatus; perh. Akin to E. Strew.
Source: Websters Dictionary
(01 Mar 1998)
alpha substance A filamentous plasmatic material, beaded with granules, demonstrable by means of vital staining in the immature red blood cells.
Synonym: alpha substance, filar mass, filar substance, substantia reticularis, substantia reticulofilamentosa.
Synonym: reticular formation.
(05 Mar 2000)
anterior perforated substance A region at the base of the brain through which numerous small branches of the anterior and middle cerebral arteries (lenticulostriate arteries) enter the depth of the cerebral hemisphere; it is bordered medially by the optic chasm and anterior half of the optic tract, rostrally and laterally by the lateral olfactory stria; its anteromedial part corresponds to the olfactory tubercle.
Synonym: substantia perforata anterior, locus perforatus anticus, olfactory area.
(05 Mar 2000)
autacoid substance A substance formed metabolically by one set of cells, which alters the function of other cells. (This term is sometimes used in place of the term hormone.)
(05 Mar 2000)
bacteriotropic substance Opsonin or other substance that alters bacterial cells in such a manner that they are more susceptible to phagocytic action.
(05 Mar 2000)
basophilic substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
basophil substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
blood group substance Blood group-specific substances A and B, solution of complexes of polysaccharides and amino acids that reduces the titre of anti-A and anti-B isoagglutinins in serum from group O persons; used to render group O blood reasonably safe for transfusion into persons of group A, B, or AB, but does not affect any incompatibility that results from various other factors, such as Rh.
(05 Mar 2000)
vasodepressor substance An incompletely characterised chemical, apparently produced during liver damage, that tends to decrease vascular pressures and relax arterial walls.
(05 Mar 2000)
gelatinous substance The apical part of the posterior horn (dorsal horn; posterior gray column) of the spinal cord's gray matter, composed largely of very small nerve cells; its gelatinous appearance is due to its very low content of myelinated nerve fibres.
Synonym: substantia gelatinosa, Rolando's gelatinous substance, Rolando's substance.
(05 Mar 2000)
glandular substance of prostate The glandular tissue of the prostate as distinct from the stroma and capsule.
Synonym: substantia glandularis prostatae.
(05 Mar 2000)
Reichstein's substance One of several steroids; e.g., Reichstein's substance F (cortisone), Reichstein's substance H (corticosterone), Reichstein's substance M (cortisol), Reichstein's substance Q (cortexone), and Reichstein's substance S (cortexolone).
Synonym: Reichstein's compound.
(05 Mar 2000)
released substance <haematology> A polysaccharide precursor molecule which is used to make the antigens on the surface of human blood cells that are classified in the ABO blood group system.
(09 Oct 1997)
central and lateral intermediate substance The central gray matter of the spinal cord surrounding the central canal.
Synonym: substantia intermedia centralis et lateralis, anterior gray column, Stilling's gelatinous substance, substantia gelatinosa centralis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gray whale
    ·¯¹Ù½ºÆ®°í·¡(ÅÂÆò¼§»ê)
  • gray wolf
    =TIMBER WOLF
  • gray zone
    À̵µ Àúµµ ¾Æ´Ñ(»óÅÂ);¾Ö¸ÅÇÑ (¹üÀ§);ȸ»ö Áö´ë(ÀÇ)(¾î´À Ãʰ­´ë±¹ÀÇ ¼¼·ÂÇÏ¿¡ ÀÖ´Â Áö ¾Ö¸ÅÇÑ Áö¿ª)
  • iron gray
    öȸ»öÀÇ
  • iron gray
    öȸ»öÀÇ
  • pearl gray
    ÁøÁÖºû
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á